Replies to post #4611 on Cytodyn Inc (CYDY)

[Amatuer17]

The initial exclusion for adjunct was only those ccr5 patients that have developed resistance to 2 or 3 groups. That was stringent exclusion.

In fact they had some 25+ site and many were closed as they could not recruit.

Monotherapy may be somewhat easier.